PURE Bioscience, Inc. (PURE) Return on equity 2017–2023
PURE Bioscience, Inc. (PURE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1456.2%FY2023 · since FY2017: -485.5% → -1456.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -1456.2% | -1366.9 pp |
| FY2022 | -89.3% | -19.7 pp |
| FY2021 | -69.6% | -69.7 pp |
| FY2020 | 0.1% | +550.8 pp |
| FY2019 | -550.8% | +30.2 pp |
| FY2018 | -581.0% | -95.4 pp |
| FY2017 | -485.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice